Albeir Y. Mousa

Albeir Y. Mousa

Auto-generated profile, based on publicly available information

Albeir Y. Mousa

Department of Surgery, Robert C. Byrd Health Sciences Center, West Virginia University, Vascular Center of Excellence, Charleston Area Medical Center, Charleston, WV, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2009 in Vascular
Verified
Journal Article
Closed access
PDF file
AMAlbeir Y. Mousa
Albeir Y. Mousa
BCBrian W. Coyle
Brian W. Coyle
JAJohn Affuso
John Affuso
PHPaul B. Haser
Paul B. Haser
TVTodd R. Vogel
Todd R. Vogel
AGAlan M. Graham
Alan M. Graham
Isolated dissection of the origin of both celiac and superior mesenteric arteries is a rare vascular pathology with limited management guidelines. The presentation is generally nonspecific, most often manifesting with epigastric pain radiating to the back. A high diagnostic index of suspicion and stepwise management are essential for a successful outcome. This case report details the clinical course of a 57-year-male who presented with a 2-week history of epigastric discomfort with back pain and was found to have focal celiac artery dissection with aneurysmal dilation of 1.2 cm. His vital signs were stable, and the physical examination was unremarkable. At this time, he was placed on antiplatelet medication and was scheduled for endovascular repair of his celiac aneurysm with a covered stent graft. Two weeks later, recurrent abdominal pain prompted a repeat computed tomographic scan that revealed sequential superior mesenteric artery (SMA) dissection. The patient was admitted and anticoagulated. A complete workup ruled out underlying collagen vascular and autoimmune pathology. He remained stable, with significant symptomatic improvement. After 6 months, anticoagulation was discontinued and antiplatelet therapy was instituted for long-term management. Subsequent operative or endovascular intervention was not required. The patient was continuing to do well on his 18-month clinical follow-up. There are 71 cases of SMA and 12 cases of celiac artery dissection in the literature. This report outlines this rare presentation of isolated, proximal sequential celiac artery and SMA dissection. This case illustrates that conservative management may be warranted in uncomplicated, isolated visceral arterial dissection.

25 April 2016 in Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
AMAlbeir Y. Mousa
Albeir Y. Mousa
JBJoseph Bozzay
Joseph Bozzay
MBMike Broce
Mike Broce
MYMichael Yacoub
Michael Yacoub
PSPatrick A. Stone
Patrick A. Stone
AAAli F. AbuRahma
Ali F. AbuRahma
The purpose of this study was to identify significant predictors of long-term mortality after elective endovascular abdominal aortic aneurysm repair (EVAR). We included all cases with elective EVAR based on a national data set from the Society for Vascular Surgery Patient Safety Organization. Clinical and anatomic variables were analyzed with a Kaplan-Meier and Cox-regression model to determine predictors of mortality and develop a score equation to categorize patients into low, medium, and high long-term mortality risk. A total of 5678 patients with EVAR were included with an average age of 73.6 ± 8.2 years. The majority were male (81.6%) with a history of smoking (86.1%). There were 3 deaths within 30 days (0.1%). Several factors were associated with poor survival: unstable angina (hazard ratio [HR], 2.8; P = .008), dialysis (HR, 3.7; P < .001), estimated glomerular filtration rate (eGFR) 80 (HR, 3.2; P < .001), age 75 to 79 (HR, 2.2; P < .001), chronic obstructive pulmonary disease on oxygen (HR, 3.3; P < .001), aortic diameter >5.8 cm (HR, 1.2; P = .043), and high risk for surgery (HR, 1.4; P = .043). Preoperative aspirin use and body mass index 25 to 35 were both found to be protective (HR, 0.78; P = .017 and HR, 0.8; P = .024, respectively). With our scoring model, 5- and 10-year survival rates for patients with low, medium, and high risk were 89.2%, 80.7%, and 64.1% and 77.2%, 60.1%, and 40.1%, respectively (P < .001). Ten-year survival following EVAR in patients with a high-risk score utilizing the model provided was 40.1%. Patients with multiple comorbidities at risk for decreased long-term survival can be identified with our model, which is more applicable for high-volume contemporary institutions.

1 February 2007 in Vascular
Verified
Journal Article
Closed access
AMAlbeir Y. Mousa
Albeir Y. Mousa
RBRobert B. Beauford
Robert B. Beauford
LFLucio Flores
Lucio Flores
PFPeter L. Faries
Peter L. Faries
PPPrem Patel
Prem Patel
RFRichard Fogler
Richard Fogler
Use of endovascular interventions for arterial occlusive lesions continues to increase. With the evolution of the technology supporting these therapeutic measures, the results of these interventions continue to improve. In general, a comparison of techniques for revascularization of iliac occlusive diseases shows similar initial technical success rates for open versus percutaneous transluminal angioplasty. Angioplasty is often associated with lower periprocedural morbidity and mortality rates. Conversely, surgery frequently provides greater long-term patency, although late failure of percutaneous therapies may occur but still can be treated successfully with reintervention. The perpetual buildup of experience with angioplasty and stenting will eventually characterize its role in the management of occlusive disease. This review outlines the current consensus and applicability of endovascular management of iliac occlusive diseases.

1 April 2006 in Vascular
Verified
Journal Article
Closed access
AMAlbeir Y. Mousa
Albeir Y. Mousa
RBRobert B. Beauford
Robert B. Beauford
PHPeter William Henderson
Peter William Henderson
PPPrem Patel
Prem Patel
PFPeter L. Faries
Peter L. Faries
RFRichard Fogler
Richard Fogler
Popliteal artery aneurysms (PAAs) are the most frequent peripheral aneurysm with a significant morbidity if left untreated. Open surgical technique is still considered the gold standard; however the revolution in endovascular repair has proven to be a valid alternative option in selected patients. The role of endovascular treatment in PAA is still considered in its infancy. In addition, the indications for use of endovascular stents as compared to standard open surgery have not yet been fully defined and more studies are warranted to characterize the durability of this technique. This article describes the general principles of the natural history, clinical presentation, and long-term limb salvage and survival outcomes for patients with such aneurysms. It also details the features and results for the devices in current use and highlights the current consensus in the management of PAA.

7 January 2015 in Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
AMAlbeir Y. Mousa
Albeir Y. Mousa
SAShadi Abu-Halimah
Shadi Abu-Halimah
GGGurpreet Gill
Gurpreet Gill
MYMichael Yacoub
Michael Yacoub
PSPatrick Stone
Patrick Stone
AAAli F. AbuRahma
Ali F. AbuRahma
Acute type B aortic dissection (ATBAD) is a medical emergency that is a common occurrence in patients with atherosclerotic disease. The presentation is usually severe, with tearing pain that radiates to the back, and various levels of end-organ ischemia and malperfusion, even rupture, may occur. Everyone agrees that prompt and aggressive blood pressure control with β-blockers and nitroprusside is imperative, but when to surgically intervene is still not well characterized. However, the advent of minimally invasive stent graft placement has reshaped our thoughts regarding therapeutic intervention for ATBAD. This review is an attempt to define the current surgical indications for treating ATBAD.

27 November 2014 in Vascular
Verified
Journal Article
Closed access
AMAlbeir Y Mousa
Albeir Y Mousa
SAShadi AbuHalimah
Shadi AbuHalimah
MYMichael Yacoub
Michael Yacoub
ISIqra Sheikh
Iqra Sheikh
AAAli F AbuRahma
Ali F AbuRahma
The placement of permanent inferior vena cava filters has definite indications and some filters have been shown to be more problematic in the long term than others. This report outlines the technique for TRAPEASE® filter removal in two patients. The first filter was retrieved four weeks after insertion and the second filter was retrieved 14 months after it was inserted at another institution. A planned approach for retrieval is described in these case reports.